Pharma Focus Asia

Nagase Viita launches SOLBIOTETM, a new brand of injectable-grade saccharide excipients for biopharmaceuticals.

Saturday, June 08, 2024

Nagase Viita Co., Ltd. (Headquarters: Shimoishii, Kita-ku, Okayama; Representative Director: Naoki Yasuba), a member of the NAGASE Group, has launched a new product brand, SOLBIOTETM, featuring our saccharide-based pharmaceutical excipients of high-purity and low-endotoxin TREHALOSE SG and MALTOSE PH.

SOLBIOTETM portfolio is an excellent protein stabilizer, protecting cells, nucleotides, and exosomes from various damage caused by stressors such as drying, freezing, and thawing. It preserves the quality of antibody therapeutics, vaccines, and other biopharmaceuticals, which are inherently unstable during manufacturing, storage, and distribution, requiring adequate cold-chain management.

Nagase Viita has a long history of harnessing the power of nature and an expertise in biotechnology, which led us to be the first to successfully mass produce trehalose utilizing starch and enzymes. We are committed to providing a stable supply of safe, high-quality excipients through our integrated manufacturing from saccharide production to refining.

We will further pursue the development of new saccharide excipients for our SOLBIOTETM portfolio and its advanced pharmaceutical applications, bringing pharmaceutical solutions for universal health.

The name SOLBIOTETM comes from “Sol + Bio”, developed by our Biotechnology and starch, a gift from the sun (Sol meaning the sun in Latin), providing Solutions to Biopharmaceuticals.

◆Inquiries on press release:
Pharmaceutical Business Department, Nagase Viita Co., Ltd.



magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024